Trial intelligence / Profile preview

Postoperative intrathecal analgesia for lumbar spine surgery

PACTR202304865602085Phase 3Not yet recruiting

Sponsor
Dr. Mona Raafat Elghamry
Start
May 2023
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of morphine and nalbuphine in postoperative pain (2 arms), sponsored by Dr. Mona Raafat Elghamry. Primary endpoint: Duration of effective analgesia. Planned start May 2023; status: not yet recruiting.

02

Drugs

morphinenalbuphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202304865602085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202304865602085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call